TSE:L

Loblaw Companies Ltd (L.TO)

66.47
+1.70 (2.62%)
as of Jun 24, 2026, 5:09:45 pm Market Open.
323 watching
0
Investor Insights
star iconJun 24, 2026, 12:00 am

This summary was created by AI, based on 15 opinions in the last 12 months.

Loblaw Companies Ltd. is Canada's leading food and drug retailer, effectively navigating challenges posed by inflation and competition. Analysts commend its strategic focus on discount formats like No Frills and the strong performance of its private labels, particularly the No Name brand. The acquisition of Shoppers Drug Mart has proven beneficial, generating robust free cash flow, and establishing a solid market position with organic growth prospects. While some experts express concerns about its current valuation being high, the company remains a reliable defensive choice in uncertain economic times. Overall, experts acknowledge its significant market share, operational efficiencies, and impressive revenue growth despite mixed sentiment regarding its valuation relative to competitors.

consensus icon
Consensus
Positive
valuation icon
Valuation
Overvalued
review icon
Similar
CST, CST
BUY
Reliable earnings stream.
BUY
Good safe haven. 10% off their highs. Prefers Sobeys.
TOP PICK
Track record is tremendous and should continue.
BUY ON WEAKNESS
Prefers owning George Weston as a cheaper way to have access to Loblaws. Buy below $50 if possible.
BUY
A very strong franchise.Good price.
WEAK BUY
Worries about competition.
BUY
Will deliver good earnings/growth in the next 2/3 years.
DON'T BUY
Nervous about what Walmart is doing in the US.
BUY
Defensive stock. Long term outlook is good.
HOLD
Impressive retailing. Good long core holding.
BUY
Good operators. Quality. Good growth.
BUY
Has been weakening a bit because of their earnings. 25 X earnings.
BUY
Good price. Prefers over Sobeys.
DON'T BUY
Expensive.
BUY
Good price. Yield is pretty good. Expanding into Quebec.
Showing 616 to 630 of 706 entries